CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-22 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion | +4,432 | 33,241 | ||
| 2018-05-22 | Ruff Shamim SVP, Chief Regulatory Affairs | Shares withheld for taxes | −1,305 | $89.22 | $116K | 31,936 |
| 2018-05-22 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion · Restricted Stock Units | −4,432 | 0 | ||
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion | +469 | $13.90 | $7K | 27,514 |
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Shares withheld for taxes | −80 | $81.22 | $6K | 27,434 |
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion | +2,031 | $26.24 | $53K | 29,465 |
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Shares withheld for taxes | −656 | $81.22 | $53K | 28,809 |
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion · Stock option (right to buy) | −469 | 6,134 | ||
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion · Stock option (right to buy) | −2,031 | 10,066 | ||
| 2018-03-05 | Ruff Shamim SVP, Chief Regulatory Affairs | Grant or award · Stock option (right to buy) | +70,000 | 70,000 | ||
| 2017-11-06 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion | +10,000 | $14.76 | $148K | 37,045 |
| 2017-11-06 | Ruff Shamim SVP, Regulatory Affairs & Qual | Sale | −10,000 | $55.00 | $550K | 27,045 |
| 2017-11-06 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion · Non-Qualified Stock Options (right to buy) | −10,000 | $14.76 | $148K | 31,144 |
| 2017-10-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion | +11,500 | $14.76 | $170K | 38,545 |
| 2017-10-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Sale | −11,500 | $50.00 | $575K | 27,045 |
| 2017-10-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion · Non-Qualified Stock Options (right to buy) | −11,500 | $14.76 | $170K | 41,144 |
| 2017-08-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion | +8,865 | 29,927 | ||
| 2017-08-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Shares withheld for taxes | −2,882 | $37.88 | $109K | 27,045 |
| 2017-08-03 | Ruff Shamim SVP, Regulatory Affairs & Qual | Exercise or conversion · Restricted Stock Units | −8,865 | 0 |
Page 1 of 1 · 19 trades